+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Complementary and Alternative Medicine For Anti-Aging and Longevity Market Size, Share and Growth Outlook, 2026: Analysis By Intervention Type: (Traditional Alternative Medicine, Mind-Body Intervention, External Energy Healing, Sensory Healing), By Customer: (High Net Worth , Very High Net Worth , Other Consumers), By End-Use: (Consumers, Healthcare Practitioners, Corporate Wellness Programs, Other End Users) Companies, and Country Forecast, 2021 to 2034

Global Complementary and Alternative Medicine For Anti-Aging and Longevity Market size is forecast to increase from $84.96 Billion in 2026 to $304.51 Billion in 2034 at a CAGR of 17.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006497
Pages: 228 Pages

Competent Cells Market Size, Share and Growth Outlook, 2026: Analysis By Cell Type (Chemically Competent Cells, Electrocompetent Cells, Ultracompetent Cells), By Organism Type (Bacterial Competent Cells, Yeast Competent Cells, Mammalian Competent Cells, Plant Competent Cells), By Application (Molecular Cloning and Subcloning, Recombinant Protein Expression, Plasmid and Library Construction, Mutagenesis and Directed Evolution, CRISPR), By Competency Level (High Efficiency Competent Cells, Moderate Efficiency Competent Cells, Low Efficiency Competent Cells), By End User (Academic and Research Institutes, Biotechnology and Biopharmaceutical Companies, Contract Research Organizations , Diagnostic and Clinical Research Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Competent Cells Market size is forecast to increase from $2.71 Million in 2026 to $5.24 Million in 2034 at a CAGR of 8.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006496
Pages: 227 Pages

Companion Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Assays and Kits, Instruments and Analyzers, Software and Services), By Technology (Polymerase Chain Reaction , Next-Generation Sequencing , Immunohistochemistry , In Situ Hybridization , Liquid Biopsy), By Indication (Oncology , Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Autoimmune Disorders), By End User (Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations , Hospitals and Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Companion Diagnostics Market size is forecast to increase from $9.99 Billion in 2026 to $25.45 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006495
Pages: 211 Pages

Companion Animal Vaccines Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Core Vaccines, Non-Core Vaccines, Therapeutic Vaccines), By Vaccine Technology (Live Attenuated Vaccines, Inactivated , Recombinant Vaccines, DNA & mRNA Vaccines, Toxoid Vaccines), By Animal Type (Canine , Feline , Equine , Avian , Small Mammals ), By Route of Administration (Parenteral , Oral, Intranasal), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Online Retail) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Vaccines Market size is forecast to increase from $4.53 Billion in 2026 to $8.45 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006494
Pages: 217 Pages

Companion Animal Specialty Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Product (Monoclonal Antibodies , Targeted Oncological Therapeutics , Specialized Biologics and Immunotherapies, Behavioral and Neuropharmacological Medications, Specialty Chronic Care Drugs , Long-Acting Injectable Therapeutics), By Animal Type (Dogs , Cats , Horses ), By Route of Administration (Injectable , Oral Formulations , Topical ), By Distribution Channel (Veterinary Specialized Hospitals, In-Clinic Veterinary Pharmacies, Dedicated Online Pet Pharmacies , Retail and Commercial Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Specialty Drugs Market size is forecast to increase from $18.53 Billion in 2026 to $32.32 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006493
Pages: 219 Pages

Companion Animal Rehabilitation Services Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Therapeutic Exercises & Physiotherapy, Hydrotherapy , Laser Therapy , Manual Therapy , Electrotherapy , Acupuncture and Alternative Services), By Animal Type (Dogs , Cats , Horses ), By Clinical Indication (Post-Surgery Rehabilitation , Acute & Chronic Diseases , Neurological Conditions and Spinal Injuries, Weight Management and Obesity Control, Sports Performance and Conditioning), By End-User (Specialized Veterinary Rehabilitation Centers, Multi-Specialty Veterinary Hospitals & Clinics, Animal Rescue Shelters and Sanctuaries, Mobile and Homecare Rehabilitation Providers) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Rehabilitation Services Market size is forecast to increase from $987.81 Million in 2026 to $2211.64 Million in 2034 at a CAGR of 10.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006492
Pages: 211 Pages

Companion Animal Regenerative Medicine Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Stem Cell Therapy, Platelet-Rich Plasma , Tissue Allografts and Amniotic Biologics, Other Cellular Therapies), By Animal Type (Dogs , Cats , Horses , Other Small Companion Animals), By Indication (Orthopedic & Musculoskeletal Disorders, Trauma and Wound Care, Dermatology and Skin Inflammation, Immune, Inflammatory, and Ophthalmic Disorders), By Sourcing Modality (Autologous Therapies, Allogeneic Therapies), By End-User (Veterinary Specialty Hospitals, Veterinary Clinics and Regenerative Medicine Centers, Academic & Veterinary Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Regenerative Medicine Market size is forecast to increase from $1.49 Billion in 2026 to $3.12 Billion in 2034 at a CAGR of 9.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006491
Pages: 221 Pages

Companion Animal Postoperative Pain Management Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class: (Non-Steroidal Anti-Inflammatory Drugs , Opioids, Local Anesthetics, Alpha-2 Adrenoceptor Agonists, Others), By Animal Type: (Dogs, Cats, Horses), By Surgery Type: (Orthopedic Surgery, Soft Tissue Surgery, Dental Surgery, Ophthalmic Surgery), By End-User: (Veterinary Hospitals, Veterinary Surgical Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Postoperative Pain Management Therapeutics Market size is forecast to increase from $256.26 Million in 2026 to $525.03 Million in 2034 at a CAGR of 9.38% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006490
Pages: 230 Pages

Companion Animal Pharmaceuticals Market Size, Share and Growth Outlook, 2026: Analysis By Product Type: (Anti-Infectives, Parasiticides, Anti-Inflammatories, Anesthetics & Analgesics, Vaccines, Others), By Animal Type: (Dogs, Cats, Horses), By Route of Administration: (Oral, Injectable, Topical), By End-User: (Veterinary Hospitals & Clinics, Homecare) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Pharmaceuticals Market size is forecast to increase from $19.29 Billion in 2026 to $32.41 Billion in 2034 at a CAGR of 6.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006489
Pages: 227 Pages

Companion Animal Osteoarthritis Market Size, Share and Growth Outlook, 2026: Analysis By Animal Type: (Dogs, Cats, Horses), By Product Type: (Anti-Inflammatory Drugs, Disease-Modifying Osteoarthritis Drugs , Nutraceuticals, Regenerative Therapies), By Distribution Channel: (Veterinary Hospitals, Veterinary Clinics, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Companion Animal Osteoarthritis Market size is forecast to increase from $4.11 Billion in 2026 to $7.17 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006488
Pages: 225 Pages